HARE-40: HPV Anti-CD40 RNA vaccinE

Clinical trial NCT03418480 · COMPLETED

Trial details

NCT number: NCT03418480
Sponsor: University of Southampton
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Human Papilloma Virus Related Carcinoma Head and Neck Neoplasm Cervical Neoplasm Penile Neoplasms Malignant Unknown Primary Tumors

Start date: 2017-04-11
Primary completion: 2023-11-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.